JPWO2022138909A1 - - Google Patents

Info

Publication number
JPWO2022138909A1
JPWO2022138909A1 JP2022571676A JP2022571676A JPWO2022138909A1 JP WO2022138909 A1 JPWO2022138909 A1 JP WO2022138909A1 JP 2022571676 A JP2022571676 A JP 2022571676A JP 2022571676 A JP2022571676 A JP 2022571676A JP WO2022138909 A1 JPWO2022138909 A1 JP WO2022138909A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022571676A
Other languages
Japanese (ja)
Other versions
JPWO2022138909A5 (https=
JP7359973B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2022138909A1 publication Critical patent/JPWO2022138909A1/ja
Publication of JPWO2022138909A5 publication Critical patent/JPWO2022138909A5/ja
Priority to JP2023166660A priority Critical patent/JP7432053B2/ja
Application granted granted Critical
Publication of JP7359973B2 publication Critical patent/JP7359973B2/ja
Priority to JP2024014953A priority patent/JP7484030B2/ja
Priority to JP2024074490A priority patent/JP2024097852A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30Oestrogens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/16Cyclodextrin; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02Oxygen as only ring hetero atoms
    • C12P17/06Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • General Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physiology (AREA)
  • Obesity (AREA)
  • Mycology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Botany (AREA)
JP2022571676A 2020-12-24 2021-12-24 エクオールの経口による血中吸収性を向上させる方法及びβ-シクロデキストリンからなるエクオールの血中吸収促進剤 Active JP7359973B2 (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2023166660A JP7432053B2 (ja) 2020-12-24 2023-09-28 シクロデキストリンにエクオールが包接された包接体を含有するエクオール吸収性組成物
JP2024014953A JP7484030B2 (ja) 2020-12-24 2024-02-02 シクロデキストリンにエクオールが包接された包接体の製造方法
JP2024074490A JP2024097852A (ja) 2020-12-24 2024-05-01 シクロデキストリンにエクオールが包接された包接体の製造方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020215247 2020-12-24
JP2020215247 2020-12-24
PCT/JP2021/048167 WO2022138909A1 (ja) 2020-12-24 2021-12-24 シクロデキストリンにエクオールが包接された包接体、該包接体を含有するエクオール吸収性組成物、及びこれらの製造方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023166660A Division JP7432053B2 (ja) 2020-12-24 2023-09-28 シクロデキストリンにエクオールが包接された包接体を含有するエクオール吸収性組成物

Publications (3)

Publication Number Publication Date
JPWO2022138909A1 true JPWO2022138909A1 (https=) 2022-06-30
JPWO2022138909A5 JPWO2022138909A5 (https=) 2023-08-18
JP7359973B2 JP7359973B2 (ja) 2023-10-11

Family

ID=82158029

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2022571676A Active JP7359973B2 (ja) 2020-12-24 2021-12-24 エクオールの経口による血中吸収性を向上させる方法及びβ-シクロデキストリンからなるエクオールの血中吸収促進剤
JP2023166660A Active JP7432053B2 (ja) 2020-12-24 2023-09-28 シクロデキストリンにエクオールが包接された包接体を含有するエクオール吸収性組成物
JP2024014953A Active JP7484030B2 (ja) 2020-12-24 2024-02-02 シクロデキストリンにエクオールが包接された包接体の製造方法
JP2024074490A Pending JP2024097852A (ja) 2020-12-24 2024-05-01 シクロデキストリンにエクオールが包接された包接体の製造方法

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2023166660A Active JP7432053B2 (ja) 2020-12-24 2023-09-28 シクロデキストリンにエクオールが包接された包接体を含有するエクオール吸収性組成物
JP2024014953A Active JP7484030B2 (ja) 2020-12-24 2024-02-02 シクロデキストリンにエクオールが包接された包接体の製造方法
JP2024074490A Pending JP2024097852A (ja) 2020-12-24 2024-05-01 シクロデキストリンにエクオールが包接された包接体の製造方法

Country Status (3)

Country Link
US (1) US20240082424A1 (https=)
JP (4) JP7359973B2 (https=)
WO (1) WO2022138909A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025070550A1 (ja) 2023-09-27 2025-04-03 Sbカワスミ株式会社 バルーン付きガイドワイヤ、カテーテルセットおよび医療用機器

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012135218A (ja) * 2010-12-24 2012-07-19 Daicel Corp エクオールの製造法、エクオール産生組成物、食品、食品添加物及び医薬品
WO2013058303A1 (ja) * 2011-10-18 2013-04-25 ラクオリア創薬株式会社 医薬組成物
JP2020058319A (ja) * 2018-10-12 2020-04-16 株式会社ダイセル 6−ヒドロキシダイゼインの製造方法
JP2020092690A (ja) * 2018-12-07 2020-06-18 学校法人東京理科大学 エクオール誘導体の産生のための組成物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6884790B2 (en) * 2002-09-09 2005-04-26 Josef Pitha Verifiable absorption drug delivery form based on cyclodextrins
TW201118175A (en) * 2003-06-30 2011-06-01 Otsuka Pharma Co Ltd Equol-producing lactic acid bacteria-containing composition
JP2006111534A (ja) * 2004-10-12 2006-04-27 Bio Taxol:Kk クルクミン水溶液の製造方法
EP1961309A4 (en) * 2005-12-06 2010-01-20 Otsuka Pharma Co Ltd EMBRYONIC AXIS FERMENTATION PRODUCT OF SOYBEAN CONTAINING EQUOL, AND METHOD FOR PRODUCING THE SAME
JP2008061584A (ja) * 2006-09-08 2008-03-21 Asano Kozo エクオール生産能を持つ微生物及び飲食品、医薬品、動物飼料およびその製造法
KR20100015996A (ko) * 2007-04-09 2010-02-12 가부시끼가이샤 하야시바라 세이부쓰 가가꾸 겐꾸조 에쿠올류를 유효 성분으로 함유하는 미백제
JP5355395B2 (ja) * 2007-06-13 2013-11-27 大塚製薬株式会社 エクオール含有抽出物及びその製造方法、エクオール抽出方法、並びにエクオールを含む食品
JP5916132B2 (ja) * 2010-09-08 2016-05-11 株式会社ダイセル エクオールの製造方法
JP5851685B2 (ja) * 2010-12-24 2016-02-03 株式会社ダイセル エクオールの製造方法、エクオール産生組成物、食品、食品添加物及び医薬品
JP6005453B2 (ja) * 2012-09-14 2016-10-12 株式会社ダイセル オルニチンとエクオールを含む組成物
JP6132398B2 (ja) * 2013-06-04 2017-05-24 株式会社ダイセル エクオール以外のイソフラボン類の含有量が低いエクオール含有組成物
JP2015139424A (ja) * 2014-01-30 2015-08-03 株式会社ダイセル エクオール含有組成物の製造方法
KR102514781B1 (ko) * 2014-09-10 2023-03-28 시스템 비올로기 아게 이소플라반 및 이의 중간체의 합성
JP2019011370A (ja) * 2018-10-24 2019-01-24 株式会社ダイセル エクオール含有組成物の製造方法
WO2020090137A1 (ja) * 2018-10-30 2020-05-07 太陽化学株式会社 容器詰飲料
JP7451185B2 (ja) * 2019-01-22 2024-03-18 株式会社ダイセル 新規微生物およびその利用

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012135218A (ja) * 2010-12-24 2012-07-19 Daicel Corp エクオールの製造法、エクオール産生組成物、食品、食品添加物及び医薬品
WO2013058303A1 (ja) * 2011-10-18 2013-04-25 ラクオリア創薬株式会社 医薬組成物
JP2020058319A (ja) * 2018-10-12 2020-04-16 株式会社ダイセル 6−ヒドロキシダイゼインの製造方法
JP2020092690A (ja) * 2018-12-07 2020-06-18 学校法人東京理科大学 エクオール誘導体の産生のための組成物

Also Published As

Publication number Publication date
JP7432053B2 (ja) 2024-02-15
WO2022138909A1 (ja) 2022-06-30
JP7484030B2 (ja) 2024-05-15
JP2024097852A (ja) 2024-07-19
JP2023165927A (ja) 2023-11-17
JP2024036485A (ja) 2024-03-15
US20240082424A1 (en) 2024-03-14
JP7359973B2 (ja) 2023-10-11

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
JPWO2022138909A1 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021015500A2 (https=)
JPWO2022202961A1 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)
BR102021016375A2 (https=)
BR102021016176A2 (https=)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230620

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230620

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20230620

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230725

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230810

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230829

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230928

R150 Certificate of patent or registration of utility model

Ref document number: 7359973

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150